- $1.18bn
- $1.13bn
- $249.46m
- 92
- 17
- 56
- 55
Annual income statement for Model N, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 141 | 161 | 193 | 219 | 249 |
| Cost of Revenue | |||||
| Gross Profit | 75.1 | 95.6 | 107 | 122 | 141 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 156 | 168 | 208 | 232 | 283 |
| Operating Profit | -15 | -6.61 | -14.4 | -13 | -33.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18.3 | -12.9 | -29 | -27.2 | -31.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.3 | -13.7 | -29.7 | -28.6 | -33.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.3 | -13.7 | -29.7 | -28.6 | -33.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.3 | -13.7 | -29.7 | -28.6 | -33.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.599 | -0.396 | -0.793 | -0.779 | -0.387 |